AC Immune files for U.S. IPO to develop Alzheimer's drug

May 31, 2016 7:33 PM

13 0

Swiss biotech firm AC Immune SA filed with U.S. regulators on Tuesday to raise up to $50 million in an initial public offering of common stock.

AC Immune, backed by German billionaire Dietmar Hopp, said it plans to use proceeds from the IPO to develop products, including Alzheimer's drug crenezumab.

Also read: KKR to buy majority stake in cybersecurity firm Optiv from Blackstone

Read more

To category page